Sitagliptin Impurity 106 - Request Quote
Sitagliptin Impurity 106
| SZ CAT No: | SZ-S009178 |
| CAS No | NA |
| Mol.F. | C21H23F6N5O3 |
| Mol.Wt. | 507.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sitagliptin Impurity 106 is chemically (R)-Tert-butyl(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamic acid. Sitagliptin Impurity 106 is supplied with detailed characterization data compliant with regulatory guideline. Sitagliptin Impurity 106 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sitagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Sitagliptin Impurity 106
Purchase Sitagliptin Impurity 106
Sitagliptin Impurity 106 suppliers
Sitagliptin Impurity 106 manufacturers
Sitagliptin Impurity 106 price
Order Sitagliptin Impurity 106
Enquire Sitagliptin Impurity 106
Sitagliptin Impurity 106 cost
Sitagliptin Impurity 106 Supplier
Sitagliptin Impurity 106 Distributor
Sitagliptin Impurity 106 for Method Validation
Sitagliptin Reference Standard
Sitagliptin Impurity 106 for ANDA Filing
Sitagliptin Impurity 106 for Forced Degradation Studies
Sitagliptin Impurity 106 Identification Standards
Sitagliptin Impurity 106 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


